Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS is a federal award for 257-Network Contract Office 17 (36C257) held by Optum Infusion Services 308, LLC. Estimated value $225K ($225K obligated). Current period of performance ends Oct 31, 2026. Place of performance: AMARILLO TX.
AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS
Recompete timing
PublicCurrent PoP ends Oct 31, 2026 (34 days remaining). Agencies typically plan 12–18 months ahead — at 1.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C25726N0093? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOptum Infusion Services 308, LLC — $3.6M obligated across 17 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25726N0093?
36C25726N0093 (Amarillo VA pharmacy compounding for oncology) is a 257-Network Contract Office 17 (36C257) award with a potential value of $225K, currently held by Optum Infusion Services 308, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C257-26-N-0093?
36C257-26-N-0093 is the dashed form of PIID 36C25726N0093 (Amarillo VA pharmacy compounding for oncology), held by Optum Infusion Services 308, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25726N0093?
257-Network Contract Office 17 (36C257) awarded 36C25726N0093 to Optum Infusion Services 308, LLC (potential $225K).
Who is the incumbent on 36C25726N0093?
Optum Infusion Services 308, LLC is the incumbent with $3.6M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2026.
When does Optum Infusion Services 308, LLC’s 36C25726N0093 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C25726N0093? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.